151 related articles for article (PubMed ID: 10930533)
1. A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist.
Cusack B; Jansen K; McCormick DJ; Chou T; Pang Y; Richelson E
Biochem Pharmacol; 2000 Sep; 60(6):793-801. PubMed ID: 10930533
[TBL] [Abstract][Full Text] [Related]
2. Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide.
Cusack B; Groshan K; McCormick DJ; Pang YP; Perry R; Phung CT; Souder T; Richelson E
J Biol Chem; 1996 Jun; 271(25):15054-9. PubMed ID: 8662846
[TBL] [Abstract][Full Text] [Related]
3. Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors.
Cusack B; Chou T; Jansen K; McCormick DJ; Richelson E
J Pept Res; 2000 Jan; 55(1):72-80. PubMed ID: 10667863
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist.
Labbé-Jullié C; Barroso S; Nicolas-Etève D; Reversat JL; Botto JM; Mazella J; Bernassau JM; Kitabgi P
J Biol Chem; 1998 Jun; 273(26):16351-7. PubMed ID: 9632698
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure.
Zhang G; Wang K; Li XD; Zhang DL; Xu F
Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557
[TBL] [Abstract][Full Text] [Related]
6. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological studies of novel neurotensin(8-13) mimetics.
Hong F; Zaidi J; Cusack B; Richelson E
Bioorg Med Chem; 2002 Dec; 10(12):3849-58. PubMed ID: 12413837
[TBL] [Abstract][Full Text] [Related]
8. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
Yamada M; Yamada M; Watson MA; Richelson E
Mol Pharmacol; 1994 Sep; 46(3):470-6. PubMed ID: 7935327
[TBL] [Abstract][Full Text] [Related]
9. Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).
Pang YP; Cusack B; Groshan K; Richelson E
J Biol Chem; 1996 Jun; 271(25):15060-8. PubMed ID: 8663052
[TBL] [Abstract][Full Text] [Related]
10. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.
Barroso S; Richard F; Nicolas-Ethève D; Reversat JL; Bernassau JM; Kitabgi P; Labbé-Jullié C
J Biol Chem; 2000 Jan; 275(1):328-36. PubMed ID: 10617622
[TBL] [Abstract][Full Text] [Related]
11. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin negatively modulates Akt activity in neurotensin receptor-1-transfected AV12 cells.
Liu F; Yang P; Baez M; Ni B
J Cell Biochem; 2004 Jun; 92(3):603-11. PubMed ID: 15156571
[TBL] [Abstract][Full Text] [Related]
13. Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs.
Lundquist JT; Büllesbach EE; Golden PL; Dix TA
J Pept Res; 2002 Feb; 59(2):55-61. PubMed ID: 11906607
[TBL] [Abstract][Full Text] [Related]
14. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
[TBL] [Abstract][Full Text] [Related]
16. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors.
Martin S; Botto JM; Vincent JP; Mazella J
Mol Pharmacol; 1999 Feb; 55(2):210-5. PubMed ID: 9927610
[TBL] [Abstract][Full Text] [Related]
17. Identification in the rat neurotensin receptor of amino-acid residues critical for the binding of neurotensin.
Botto JM; Chabry J; Nouel D; Paquet M; Séguéla P; Vincent JP; Beaudet A; Mazella J
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):311-7. PubMed ID: 9191107
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities.
Lundquist JT; Büllesbach EE; Dix TA
Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946
[TBL] [Abstract][Full Text] [Related]
20. NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.
Simeth NA; Bause M; Dobmeier M; Kling RC; Lachmann D; Hübner H; Einsiedel J; Gmeiner P; König B
Bioorg Med Chem; 2017 Jan; 25(1):350-359. PubMed ID: 27842797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
